Provided by Tiger Fintech (Singapore) Pte. Ltd.

Shattuck Labs, Inc.

0.7330
-0.0800-9.84%
Post-market: 0.73670.0037+0.50%19:31 EDT
Volume:125.00K
Turnover:92.85K
Market Cap:35.11M
PE:-0.49
High:0.8100
Open:0.8100
Low:0.7100
Close:0.8130
Loading ...

BRIEF-Shattuck Labs Announces Oral Presentation At Upcoming 20Th Congress Of European Crohn’S And Colitis Organization (Ecco) In Inflammatory Bowel Diseases 2025

Reuters
·
14 Feb

Shattuck Labs Announces Oral Presentation at Upcoming 20TH Congress of European Crohn’s and Colitis Organization (Ecco) in Inflammatory Bowel Diseases 2025

THOMSON REUTERS
·
14 Feb

Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025

GlobeNewswire
·
14 Feb

Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn’s and Colitis Congress

GlobeNewswire
·
04 Feb

Planet Image International Leads 3 US Penny Stocks To Consider

Simply Wall St.
·
30 Jan

Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
07 Jan

Shattuck Labs highlights upcoming key milestones in 2025

TIPRANKS
·
02 Jan

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025

THOMSON REUTERS
·
02 Jan

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025

GlobeNewswire
·
02 Jan

Shattuck Labs Announces Participation in Upcoming December Conferences

GlobeNewswire
·
25 Nov 2024

Shattuck Labs Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
16 Nov 2024

Shattuck Labs sees cash runway into 2027

TipRanks
·
15 Nov 2024

TD Cowen Reaffirms Their Buy Rating on Shattuck Labs (STTK)

TIPRANKS
·
15 Nov 2024

Shattuck Labs Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024

Shattuck Labs: Navigating Strategic Shift to Autoimmune Pipeline Amidst Financial Stability and Hold Rating

TIPRANKS
·
14 Nov 2024

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Shattuck Labs (STTK) and Astria Therapeutics (ATXS)

TIPRANKS
·
14 Nov 2024

Shattuck Labs' Cash Balance Of Approximately $90M As Of September 30, 2024; Expected To Fund Operations Into 2027

Benzinga
·
14 Nov 2024

Shattuck Labs Q3 2024 GAAP EPS $(0.33) Beats $(0.42) Estimate, Sales $3.00M May Not Be Comparable To $652.25K Estimate

Benzinga
·
14 Nov 2024

BRIEF-Shattuck Labs Q3 Net Income USD -16.675 Million

Reuters
·
14 Nov 2024

Shattuck Labs Q3 Net Income USD -16.675 Million

THOMSON REUTERS
·
14 Nov 2024